PREVIOUS
✖
Anti-HIV Drugs for COVID19
March 21 , 2020
1713 days
721
0
- The Ministry of Health and Family Welfare has issued revised guidelines on the ‘Clinical Management of COVID-19’.
- The Ministry has recommended use of drug combinations Lopinavir and Ritonavir (sold under the brand name Kaletra) depending upon the severity of the condition of a person having coronavirus infection.
- The use of this drug combination is suggested by an expert committee comprising doctors from the All India Institutes of Medical Sciences (AIIMS), experts from National Centre for Disease Control (NCDC) and World Health Organization (WHO).
- Lopinavir-Ritonavir is recommended for high-risk groups of patients aged above 60 who are suffering from diabetes mellitus, renal failure, chronic lung disease and are immuno-compromised.
- v Lopinavir-Ritonavir is used widely for controlling Human Immunodeficiency Virus (HIV) infection.
Leave a Reply
Your Comment is awaiting moderation.